Send the following on WhatsApp
Continue to ChatCOVID-19: Pfizer vaccine benefits outweigh risks in children age 5-11, says USFDA https://www.vanguardngr.com/2021/10/covid-19-pfizer-vaccine-benefits-outweigh-risks-in-children-age-5-11-says-usfda/
COVID-19: Pfizer vaccine benefits outweigh risks in children age 5-11, says USFDA https://www.vanguardngr.com/2021/10/covid-19-pfizer-vaccine-benefits-outweigh-risks-in-children-age-5-11-says-usfda/